Skip to main content
. 2019 Sep 6;8(9):1406. doi: 10.3390/jcm8091406

Table 1.

Distributions of demographic characteristics in 1199 controls and 394 patients with hepatocellular carcinoma.

Variable Controls (N = 1199)
n (%)
Patients (N = 394)
n (%)
p Value
Age (years)
≥55 912 (76.1%) 307 (77.9%) 0.451
Gender
Male 839 (70%) 273 (69.3%) 0.797
Cigarette smoking
Yes 471 (39.3%) 156 (39.6%) 0.913
Alcohol consumption
Yes 169 (14.1%) 139 (35.3%) <0.001 *
HBsAg
Positive 146 (12.2%) 167 (42.4%) <0.001 *
Anti-HCV
Positive 53 (4.4%) 178 (45.2%) <0.001 *
AFP (ng/mL) a 20.83
AST (IU/L) a 48
ALT (IU/L) a 43
Stage
III + IV 117 (29.7%)
Tumor T status
T3 + T4 112 (28.4%)
Lymph node status
N1 + N2 + N3 12 (3%)
Metastasis
M1 19 (4.8%)
Child–Pugh grade
B or C 74 (18.8%)
Liver cirrhosis
Positive 326 (82.7%)

Mann–Whitney U-test or Chi-squared test was used between healthy controls and patients with HCC. * p value < 0.05 as statistically significant. a Median level. HBsAg, hepatitis B surface antigen; HCV, hepatitis C virus; AFP, alpha-fetoprotein; AST, aspartate aminotransferase; ALT, alanine aminotransferase.